Results
Orchid Pharma Q2 FY27 Net Profit Surges 148%
• Orchid Pharma reported standalone Q2 FY27 revenue of ₹341 Cr, a 14% YoY growth, with EBITDA surging 148% to ₹52 Cr.
• The company signed two key EXBLIFEP licensing deals covering Russia and 9 Latin